Greater Cannabis Co (Greater Cannabis Co) Risk Assessment

View and export this data going back to 2018. Start your Free Trial

What is Greater Cannabis Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Greater Cannabis Co is: No Data: Cannot be evaluated.

Competitive Comparison of Greater Cannabis Co's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Greater Cannabis Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greater Cannabis Co's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greater Cannabis Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Greater Cannabis Co's Risk Assessment falls into.

Greater Cannabis Co (OTCPK:GCAN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Greater Cannabis Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Greater Cannabis Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Greater Cannabis Co (Greater Cannabis Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greater Cannabis Co Inc (OTCPK:GCAN) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

15 Walker Avenue, Suite 101, Baltimore, MD, USA, 21208

Website

https://www.gcanrx.com

Greater Cannabis Co Inc ia a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of innovative cannabinoid-based therapeutics.

Executives

Jimmy Wayne Anderson

10 percent owner

501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701